市場調査レポート

商品コード

抗肥満薬の世界市場規模、シェア、産業動向分析レポート：薬剤タイプ別、作用機序別、投与経路別（経口投与、皮下投与）、流通チャネル別、地域別展望と予測、2023～2029年

Global Anti-Obesity Drugs Market Size, Share & Industry Trends Analysis Report By Drug Type, By Mechanism of Action, By Route Of Administration (Oral Route and Subcutaneous Route), By Distribution Channel, By Regional Outlook and Forecast, 2023 - 2029

出版日: 2023年04月28日 | 発行: KBV Research

| ページ情報: 英文 220 Pages | 納期: 即納可能

価格

PDF (Single User License)

USD 3,600 565,704円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷も可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Site License)

USD 4,320 678,844円

レポートPDFを同一企業内の5名までご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷も可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprisewide License)

USD 6,048 950,382円

レポートPDFを同一企業のすべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=157.14円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

抗肥満薬市場規模は、予測期間中にCAGR10.6％で成長し、2029年には31億米ドルに達すると予測されます。

肥満治療のための臨床研究の拡大が、抗肥満薬の需要を促進すると予測されます。例えば、大企業は、肥満治療のシナリオを強化するために、見込みのある薬の代替品を作っています。抗肥満薬市場シェアの成長を促進すると予測される主な理由の1つは、副作用の少ない抗肥満治療薬の創製に向けた主要企業間の研究開発活動の活発化です。

肥満率の上昇に伴い、市場の主要企業も新製品を開発し、市場の受容を得ています。持続的効果のある薬への需要が高まっているため、市場ベンダーが新製品を創出する機会は大幅に増加すると予想されます。数多くの業界専門家やサプライヤーが、II型糖尿病と肥満の両方の有病率の上昇に伴い、その両方を治療できる医薬品の調査を行っています。この側面は、いずれ市場の拡大をサポートすると予想されます。

COVID-19の影響分析

市場への悪影響は、「対面」での病院受診に代わる遠隔医療の利用が増加し、処方薬を繰り返し購入するためにインターネット薬局を利用することで軽減されています。さらに、製薬会社は利益を維持するために、パンデミックの需要と供給を抑えることに力を注いでいます。COVID-19ウイルスは、自宅や在宅勤務の際に体重が急激に増加するため、肥満治療薬のニーズが高まっています。また、今後発売される製品、有名企業の主要なパイプライン、肥満の継続的な増加などが、COVID-19以降に市場が大きく成長する可能性につながると予想されるため、スタート段階では減少に転じたが、ポストCOVID-19の時期には大きな成長が見込まれます。

市場の成長要因

ファストフード産業の成長と不健康な食べ物の消費の増加

ファストフード業界は、消費の大幅な増加を経験しています。ファストフードの頻繁な消費は、肥満やアレルギーと関連があるとされています。ファストフードの消費は、有害物質、化学物質、過剰な塩分の存在により、腹部膨満感、胃潰瘍、潜在的には胃がんといった健康問題のリスクを高める可能性があります。ファーストフードによる塩分摂取の増加は、体内の水分保持につながり、胃痛や腹部膨満感などの不快な症状を引き起こす可能性があります。成人のファストフード消費量と富裕度の相関はプラスであり、年齢とともにマイナスになります。このため、抗肥満薬の需要が高まり、市場の成長が期待されます。

医薬品の研究開発の促進

新薬が長期的な利益を生み出すには、企業がさまざまな地域で実施する価格戦略、その価格での予測販売量、医薬品開発プロセスの成功確率が重要であり、研究開発費に大きな影響を及ぼします。さらに、政府の制度や政策が、製薬企業の研究開発に対する私的支出に大きな影響を与えます。この影響は、処方された薬の必要性を高める、基礎研究に資金を提供する、臨床試験を監督する、需要と供給の両方に影響を与えるワクチンのガイダンスを発行するなど、さまざまな方法によって達成されます。

市場抑制要因

薬物療法に対する認識と導入の欠如

フィットネス業界は、顧客、機器・サービスサプライヤー、補完部門、公的プログラムからなるエコシステムが拡大し、急速に発展しています。個人の間では、フィットネスを優先し、日々のルーチンや習慣を監視する傾向が強まっています。フィットネス業界は、世界化と知識の容易な入手により、進化し、よりダイナミックになってきています。これにより、伝統的な慣習や運動が強化され、強化されています。また、抗肥満薬に関する認知度が低いため、一般の人々が体重を減らすためにジムやその他の自然な方法が好まれており、これが予測期間中の抗肥満薬市場の成長を妨げると予想されます。

薬剤タイプの展望

薬剤タイプによって、抗肥満薬市場は処方薬とOTC（市販薬）に区分されます。処方薬セグメントは、2022年に最大収益シェアで抗肥満薬市場を独占しました。この成長は、自社製品の規制当局の承認を得ている既存企業の存在に起因しています。これらの企業は、研究開発プログラムへの投資を強化し、効率的な治療薬を発売するために戦略的提携を結ぶことで、こうした商品の受容を促進しています。

作用機序の展望

抗肥満薬市場は、作用機序によって中枢作用性抗肥満薬と末梢作用性抗肥満薬に分類されます。2022年の抗肥満薬市場では、末梢作用性セグメントがかなりの収益シェアを占めました。これは、末梢作用性抗肥満薬が、脳や食欲抑制に影響を与えることなく体重減少を助ける医薬品を指すためです。本製品は膵リパーゼ阻害剤として機能し、消化管での脂肪の分解を効果的に阻害し、最終的に腸での脂肪の吸収を減少させることにつながります。

投与経路の展望

投与経路別に見ると、抗肥満薬市場は、経口投与と皮下投与に分類されます。2022年の抗肥満薬市場では、経口投与セグメントが最大の収益シェアを示しました。これは、経口ドラッグデリバリーが、非侵襲的な性質、高い患者コンプライアンス、取り扱いの容易さ、特定の無菌状態を必要としないことから、抗肥満薬の投与経路として非常に好まれるためです。腸内でのバイオアベイラビリティや標的特異性を高めるために、さまざまなタイプのナノ粒子（NP）、ヒドロゲル、マイクロ粒子、またはそれらの組み合わせが採用されています。

流通チャネルの展望

抗肥満薬市場は、流通チャネルに基づき、病院薬局、小売薬局、オンライン薬局に区分されます。2022年の抗肥満薬市場では、オンライン薬局のセグメントが大きな収益シェアを記録しました。これは、電子薬局の利用が増加し、患者が抗肥満薬にアクセスしやすくなり、薬剤調達プロセスが効率化されたことによります。また、肥満という慢性的な疾患は、長期的な治療計画を維持するために、患者がリフィルを入手する必要があります。このため、オンライン薬局を通じた抗肥満薬の利用が増加し、予測期間中の同分野の成長を促進する可能性があります。

地域別展望

地域別に見ると、抗肥満薬市場は北米、欧州、アジア太平洋、LAMEAで分析されています。北米地域は、2022年に最大の収益シェアを獲得して抗肥満薬市場をリードしました。同地域の抗肥満薬市場の成長は、主に肥満の個人数の増加と抗肥満薬に対する多額の医療費支出によって促進されています。さらに、肥満に関連する重大な慢性疾患に対する住民の意識の高まりや、業界大手による研究開発への投資の増加による臨床試験の急増が、市場の成長を牽引すると予想されます。

北米
- 北米の市場：国別
  - 米国
  - カナダ
  - メキシコ
  - その他北米地域
欧州
- 欧州の市場：国別
  - ドイツ
  - 英国
  - フランス
  - ロシア
  - スペイン
  - イタリア
  - その他欧州地域
アジア太平洋
- アジア太平洋の市場：国別
  - 中国
  - 日本
  - インド
  - 韓国
  - シンガポール
  - マレーシア
  - その他アジア太平洋地域
ラテンアメリカ・中東・アフリカ
- ラテンアメリカ・中東・アフリカの市場：国別
  - ブラジル
  - アルゼンチン
  - アラブ首長国連邦
  - サウジアラビア
  - 南アフリカ
  - ナイジェリア
  - その他ラテンアメリカ・中東・アフリカ地域

第8章企業プロファイル

Pfizer, Inc
Boehringer Ingelheim International Gmbh
GlaxoSmithKline PLC（GSK）
Novo Nordisk A/S
Rhythm Pharmaceuticals, Inc
Gelesis Holdings Inc（PureTech Health）
Currax Pharmaceuticals LLC（Currax Holdings USA LLC）
Vivus LLC
CHEPLAPHARM Arzneimittel GmbH（Braun Beteiligungs GmbH）
KVK Tech, Inc

図表

LIST OF TABLES

TABLE 1 Global Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 2 Global Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 3 Global Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 4 Global Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 5 Global Prescription Drugs Market by Region, 2019 - 2022, USD Million
TABLE 6 Global Prescription Drugs Market by Region, 2023 - 2029, USD Million
TABLE 7 Global Over The Counter Drugs Market by Region, 2019 - 2022, USD Million
TABLE 8 Global Over The Counter Drugs Market by Region, 2023 - 2029, USD Million
TABLE 9 Global Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 10 Global Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 11 Global Centrally Acting Market by Region, 2019 - 2022, USD Million
TABLE 12 Global Centrally Acting Market by Region, 2023 - 2029, USD Million
TABLE 13 Global Peripherally Acting Market by Region, 2019 - 2022, USD Million
TABLE 14 Global Peripherally Acting Market by Region, 2023 - 2029, USD Million
TABLE 15 Global Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 16 Global Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 17 Global Oral Route Market by Region, 2019 - 2022, USD Million
TABLE 18 Global Oral Route Market by Region, 2023 - 2029, USD Million
TABLE 19 Global Subcutaneous Route Market by Region, 2019 - 2022, USD Million
TABLE 20 Global Subcutaneous Route Market by Region, 2023 - 2029, USD Million
TABLE 21 Global Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 22 Global Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 23 Global Hospital Pharmacies Market by Region, 2019 - 2022, USD Million
TABLE 24 Global Hospital Pharmacies Market by Region, 2023 - 2029, USD Million
TABLE 25 Global Retail Pharmacies Market by Region, 2019 - 2022, USD Million
TABLE 26 Global Retail Pharmacies Market by Region, 2023 - 2029, USD Million
TABLE 27 Global Online Pharmacies Market by Region, 2019 - 2022, USD Million
TABLE 28 Global Online Pharmacies Market by Region, 2023 - 2029, USD Million
TABLE 29 Global Anti-Obesity Drugs Market by Region, 2019 - 2022, USD Million
TABLE 30 Global Anti-Obesity Drugs Market by Region, 2023 - 2029, USD Million
TABLE 31 North America Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 32 North America Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 33 North America Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 34 North America Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 35 North America Prescription Drugs Market by Country, 2019 - 2022, USD Million
TABLE 36 North America Prescription Drugs Market by Country, 2023 - 2029, USD Million
TABLE 37 North America Over The Counter Drugs Market by Country, 2019 - 2022, USD Million
TABLE 38 North America Over The Counter Drugs Market by Country, 2023 - 2029, USD Million
TABLE 39 North America Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 40 North America Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 41 North America Centrally Acting Market by Country, 2019 - 2022, USD Million
TABLE 42 North America Centrally Acting Market by Country, 2023 - 2029, USD Million
TABLE 43 North America Peripherally Acting Market by Country, 2019 - 2022, USD Million
TABLE 44 North America Peripherally Acting Market by Country, 2023 - 2029, USD Million
TABLE 45 North America Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 46 North America Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 47 North America Oral Route Market by Country, 2019 - 2022, USD Million
TABLE 48 North America Oral Route Market by Country, 2023 - 2029, USD Million
TABLE 49 North America Subcutaneous Route Market by Country, 2019 - 2022, USD Million
TABLE 50 North America Subcutaneous Route Market by Country, 2023 - 2029, USD Million
TABLE 51 North America Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 52 North America Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 53 North America Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 54 North America Hospital Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 55 North America Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 56 North America Retail Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 57 North America Online Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 58 North America Online Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 59 North America Anti-Obesity Drugs Market by Country, 2019 - 2022, USD Million
TABLE 60 North America Anti-Obesity Drugs Market by Country, 2023 - 2029, USD Million
TABLE 61 US Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 62 US Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 63 US Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 64 US Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 65 US Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 66 US Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 67 US Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 68 US Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 69 US Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 70 US Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 71 Canada Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 72 Canada Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 73 Canada Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 74 Canada Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 75 Canada Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 76 Canada Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 77 Canada Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 78 Canada Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 79 Canada Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 80 Canada Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 81 Mexico Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 82 Mexico Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 83 Mexico Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 84 Mexico Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 85 Mexico Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 86 Mexico Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 87 Mexico Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 88 Mexico Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 89 Mexico Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 90 Mexico Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 91 Rest of North America Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 92 Rest of North America Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 93 Rest of North America Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 94 Rest of North America Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 95 Rest of North America Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 96 Rest of North America Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 97 Rest of North America Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 98 Rest of North America Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 99 Rest of North America Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 100 Rest of North America Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 101 Europe Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 102 Europe Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 103 Europe Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 104 Europe Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 105 Europe Prescription Drugs Market by Country, 2019 - 2022, USD Million
TABLE 106 Europe Prescription Drugs Market by Country, 2023 - 2029, USD Million
TABLE 107 Europe Over The Counter Drugs Market by Country, 2019 - 2022, USD Million
TABLE 108 Europe Over The Counter Drugs Market by Country, 2023 - 2029, USD Million
TABLE 109 Europe Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 110 Europe Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 111 Europe Centrally Acting Market by Country, 2019 - 2022, USD Million
TABLE 112 Europe Centrally Acting Market by Country, 2023 - 2029, USD Million
TABLE 113 Europe Peripherally Acting Market by Country, 2019 - 2022, USD Million
TABLE 114 Europe Peripherally Acting Market by Country, 2023 - 2029, USD Million
TABLE 115 Europe Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 116 Europe Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 117 Europe Oral Route Market by Country, 2019 - 2022, USD Million
TABLE 118 Europe Oral Route Market by Country, 2023 - 2029, USD Million
TABLE 119 Europe Subcutaneous Route Market by Country, 2019 - 2022, USD Million
TABLE 120 Europe Subcutaneous Route Market by Country, 2023 - 2029, USD Million
TABLE 121 Europe Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 122 Europe Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 123 Europe Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 124 Europe Hospital Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 125 Europe Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 126 Europe Retail Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 127 Europe Online Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 128 Europe Online Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 129 Europe Anti-Obesity Drugs Market by Country, 2019 - 2022, USD Million
TABLE 130 Europe Anti-Obesity Drugs Market by Country, 2023 - 2029, USD Million
TABLE 131 Germany Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 132 Germany Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 133 Germany Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 134 Germany Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 135 Germany Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 136 Germany Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 137 Germany Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 138 Germany Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 139 Germany Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 140 Germany Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 141 UK Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 142 UK Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 143 UK Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 144 UK Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 145 UK Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 146 UK Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 147 UK Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 148 UK Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 149 UK Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 150 UK Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 151 France Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 152 France Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 153 France Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 154 France Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 155 France Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 156 France Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 157 France Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 158 France Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 159 France Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 160 France Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 161 Russia Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 162 Russia Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 163 Russia Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 164 Russia Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 165 Russia Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 166 Russia Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 167 Russia Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 168 Russia Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 169 Russia Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 170 Russia Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 171 Spain Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 172 Spain Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 173 Spain Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 174 Spain Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 175 Spain Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 176 Spain Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 177 Spain Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 178 Spain Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 179 Spain Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 180 Spain Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 181 Italy Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 182 Italy Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 183 Italy Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 184 Italy Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 185 Italy Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 186 Italy Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 187 Italy Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 188 Italy Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 189 Italy Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 190 Italy Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 191 Rest of Europe Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 192 Rest of Europe Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 193 Rest of Europe Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 194 Rest of Europe Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 195 Rest of Europe Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 196 Rest of Europe Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 197 Rest of Europe Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 198 Rest of Europe Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 199 Rest of Europe Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 200 Rest of Europe Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 201 Asia Pacific Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 202 Asia Pacific Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 203 Asia Pacific Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 204 Asia Pacific Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 205 Asia Pacific Prescription Drugs Market by Country, 2019 - 2022, USD Million
TABLE 206 Asia Pacific Prescription Drugs Market by Country, 2023 - 2029, USD Million
TABLE 207 Asia Pacific Over The Counter Drugs Market by Country, 2019 - 2022, USD Million
TABLE 208 Asia Pacific Over The Counter Drugs Market by Country, 2023 - 2029, USD Million
TABLE 209 Asia Pacific Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 210 Asia Pacific Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 211 Asia Pacific Centrally Acting Market by Country, 2019 - 2022, USD Million
TABLE 212 Asia Pacific Centrally Acting Market by Country, 2023 - 2029, USD Million
TABLE 213 Asia Pacific Peripherally Acting Market by Country, 2019 - 2022, USD Million
TABLE 214 Asia Pacific Peripherally Acting Market by Country, 2023 - 2029, USD Million
TABLE 215 Asia Pacific Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 216 Asia Pacific Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 217 Asia Pacific Oral Route Market by Country, 2019 - 2022, USD Million
TABLE 218 Asia Pacific Oral Route Market by Country, 2023 - 2029, USD Million
TABLE 219 Asia Pacific Subcutaneous Route Market by Country, 2019 - 2022, USD Million
TABLE 220 Asia Pacific Subcutaneous Route Market by Country, 2023 - 2029, USD Million
TABLE 221 Asia Pacific Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 222 Asia Pacific Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 223 Asia Pacific Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 224 Asia Pacific Hospital Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 225 Asia Pacific Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 226 Asia Pacific Retail Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 227 Asia Pacific Online Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 228 Asia Pacific Online Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 229 Asia Pacific Anti-Obesity Drugs Market by Country, 2019 - 2022, USD Million
TABLE 230 Asia Pacific Anti-Obesity Drugs Market by Country, 2023 - 2029, USD Million
TABLE 231 China Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 232 China Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 233 China Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 234 China Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 235 China Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 236 China Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 237 China Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 238 China Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 239 China Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 240 China Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 241 Japan Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 242 Japan Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 243 Japan Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 244 Japan Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 245 Japan Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 246 Japan Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 247 Japan Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 248 Japan Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 249 Japan Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 250 Japan Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 251 India Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 252 India Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 253 India Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 254 India Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 255 India Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 256 India Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 257 India Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 258 India Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 259 India Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 260 India Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 261 South Korea Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 262 South Korea Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 263 South Korea Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 264 South Korea Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 265 South Korea Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 266 South Korea Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 267 South Korea Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 268 South Korea Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 269 South Korea Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 270 South Korea Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 271 Singapore Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 272 Singapore Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 273 Singapore Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 274 Singapore Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 275 Singapore Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 276 Singapore Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 277 Singapore Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 278 Singapore Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 279 Singapore Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 280 Singapore Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 281 Malaysia Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 282 Malaysia Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 283 Malaysia Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 284 Malaysia Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 285 Malaysia Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 286 Malaysia Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 287 Malaysia Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 288 Malaysia Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 289 Malaysia Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 290 Malaysia Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 291 Rest of Asia Pacific Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 292 Rest of Asia Pacific Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 293 Rest of Asia Pacific Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 294 Rest of Asia Pacific Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 295 Rest of Asia Pacific Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 296 Rest of Asia Pacific Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 297 Rest of Asia Pacific Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 298 Rest of Asia Pacific Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 299 Rest of Asia Pacific Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 300 Rest of Asia Pacific Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million

TABLE 301 LAMEA Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 302 LAMEA Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 303 LAMEA Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 304 LAMEA Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 305 LAMEA Prescription Drugs Market by Country, 2019 - 2022, USD Million
TABLE 306 LAMEA Prescription Drugs Market by Country, 2023 - 2029, USD Million
TABLE 307 LAMEA Over The Counter Drugs Market by Country, 2019 - 2022, USD Million
TABLE 308 LAMEA Over The Counter Drugs Market by Country, 2023 - 2029, USD Million
TABLE 309 LAMEA Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 310 LAMEA Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 311 LAMEA Centrally Acting Market by Country, 2019 - 2022, USD Million
TABLE 312 LAMEA Centrally Acting Market by Country, 2023 - 2029, USD Million
TABLE 313 LAMEA Peripherally Acting Market by Country, 2019 - 2022, USD Million
TABLE 314 LAMEA Peripherally Acting Market by Country, 2023 - 2029, USD Million
TABLE 315 LAMEA Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 316 LAMEA Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 317 LAMEA Oral Route Market by Country, 2019 - 2022, USD Million
TABLE 318 LAMEA Oral Route Market by Country, 2023 - 2029, USD Million
TABLE 319 LAMEA Subcutaneous Route Market by Country, 2019 - 2022, USD Million
TABLE 320 LAMEA Subcutaneous Route Market by Country, 2023 - 2029, USD Million
TABLE 321 LAMEA Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 322 LAMEA Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 323 LAMEA Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 324 LAMEA Hospital Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 325 LAMEA Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 326 LAMEA Retail Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 327 LAMEA Online Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 328 LAMEA Online Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 329 LAMEA Anti-Obesity Drugs Market by Country, 2019 - 2022, USD Million
TABLE 330 LAMEA Anti-Obesity Drugs Market by Country, 2023 - 2029, USD Million
TABLE 331 Brazil Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 332 Brazil Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 333 Brazil Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 334 Brazil Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 335 Brazil Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 336 Brazil Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 337 Brazil Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 338 Brazil Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 339 Brazil Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 340 Brazil Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 341 Argentina Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 342 Argentina Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 343 Argentina Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 344 Argentina Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 345 Argentina Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 346 Argentina Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 347 Argentina Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 348 Argentina Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 349 Argentina Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 350 Argentina Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 351 UAE Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 352 UAE Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 353 UAE Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 354 UAE Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 355 UAE Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 356 UAE Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 357 UAE Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 358 UAE Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 359 UAE Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 360 UAE Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 361 Saudi Arabia Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 362 Saudi Arabia Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 363 Saudi Arabia Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 364 Saudi Arabia Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 365 Saudi Arabia Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 366 Saudi Arabia Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 367 Saudi Arabia Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 368 Saudi Arabia Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 369 Saudi Arabia Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 370 Saudi Arabia Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 371 South Africa Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 372 South Africa Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 373 South Africa Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 374 South Africa Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 375 South Africa Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 376 South Africa Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 377 South Africa Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 378 South Africa Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 379 South Africa Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 380 South Africa Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 381 Nigeria Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 382 Nigeria Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 383 Nigeria Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 384 Nigeria Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 385 Nigeria Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 386 Nigeria Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 387 Nigeria Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 388 Nigeria Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 389 Nigeria Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 390 Nigeria Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 391 Rest of LAMEA Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 392 Rest of LAMEA Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 393 Rest of LAMEA Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 394 Rest of LAMEA Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 395 Rest of LAMEA Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 396 Rest of LAMEA Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 397 Rest of LAMEA Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 398 Rest of LAMEA Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 399 Rest of LAMEA Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 400 Rest of LAMEA Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 401 Key Information - Pfizer, Inc.
TABLE 402 Key Information - Boehringer Ingelheim International GmbH
TABLE 403 Key Information - GlaxoSmithKline PLC (GSK)
TABLE 404 Key information - Novo Nordisk A/S
TABLE 405 Key Information - Rhythm Pharmaceuticals, Inc
TABLE 406 Key Information - Gelesis Holdings Inc.
TABLE 407 Key Information - Currax Pharmaceuticals LLC
TABLE 408 Key Information - Vivus LLC
TABLE 409 Key Information - CHEPLAPHARM Arzneimittel GmbH
TABLE 410 Key Information - KVK Tech, Inc.

List of Figures

FIG 1 Methodology for the research
FIG 2 Global Anti-Obesity Drugs Market share by Drug Type, 2022
FIG 3 Global Anti-Obesity Drugs Market share by Drug Type, 2029
FIG 4 Global Anti-Obesity Drugs Market by Drug Type, 2019 - 2029, USD Million
FIG 5 Global Anti-Obesity Drugs Market share by Mechanism of Action, 2022
FIG 6 Global Anti-Obesity Drugs Market share by Mechanism of Action, 2029
FIG 7 Global Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2029, USD Million
FIG 8 Global Anti-Obesity Drugs Market share by Route Of Administration, 2022
FIG 9 Global Anti-Obesity Drugs Market share by Route Of Administration, 2029
FIG 10 Global Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2029, USD Million
FIG 11 Global Anti-Obesity Drugs Market share by Distribution Channel, 2022
FIG 12 Global Anti-Obesity Drugs Market share by Distribution Channel, 2029
FIG 13 Global Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2029, USD Million
FIG 14 Global Anti-Obesity Drugs Market share by Region, 2022
FIG 15 Global Anti-Obesity Drugs Market share by Region, 2029
FIG 16 Global Anti-Obesity Drugs Market by Region, 2019 - 2029, USD Million

The Global Anti-Obesity Drugs Market size is expected to reach $3.1 billion by 2029, rising at a market growth of 10.6% CAGR during the forecast period.

Obesity is a medical disease in which the body's extra body fat has built up to the point that it could be harmful to one's health. Carrying a body mass index (BMI) of 30 or more is the standard definition. It is largely acknowledged as the most significant and rapidly expanding public health issue in both industrialized and developing nations. Anti-obesity medications are ones that doctors prescribe to help the overweight. These medications reduce hunger, boost metabolism, or prevent the absorption of fat from meals.

Phentermine, liraglutide, sibutramine, and orlistat, are a few of the anti-obesity medications that are frequently recommended. The significant increase in the prevalence rate of obesity, the rise in the health risks associated with being overweight or obese, and the rise in the volume of research and development operations for multiple potential drug molecules to combat both obesity and type 2 diabetes mellitus by key market players are the main factors driving the growth of the anti-obesity drugs market share.

The expansion of clinical studies for the treatment of obesity is anticipated to fuel demand for anti-obesity medications. For instance, large corporations are creating prospective medicine substitutes to enhance the scenario for treating obesity. One of the main reasons projected to promote the growth of the anti-obesity drug market share is the increase in R&D activity among key players for the creation of anti-obesity treatments with fewer adverse effects.

As the obesity rate rises, the market's leading companies are also creating new products and gaining market acceptance. Due to the rising demand for long-lasting medications, it is anticipated that the opportunities for market vendors to create new products will increase significantly. Numerous industry experts and suppliers have been conducting research on medications that can treat both type II diabetes and obesity as a result of the increased prevalence of the disease. This aspect is anticipated to support market expansion eventually.

COVID-19 Impact Analysis

The negative effects on the market have been reduced by the rising use of telemedicine in place of "in-person" hospital visits and the use of internet pharmacies to buy repeat prescription drugs. Additionally, pharmaceutical firms put a lot of effort into keeping the pandemic's supply and demand in check to sustain their profits. Due to the rapid weight gain people experience when sitting at home or working from home, the sudden development of the COVID-19 virus has later raised the need for anti-obesity treatments. In addition, it is anticipated that forthcoming product launches, major pipeline opportunities at well-known companies, and a continuing rise in obesity will all contribute to the market's significant growth potential in the post COVID-19 period, after facing a decline in the starting phase.

Market Growth Factors

The growth of fast-food industry and increasing consumption of unhealthy food

The fast-food industry has experienced a significant increase in consumption. Frequent consumption of fast food has been associated with obesity and allergies. Consuming fast food can increase the risk of health issues such as bloating, stomach ulcers, and potentially even stomach cancer due to the presence of harmful substances, chemicals, and excessive salt. Increased salt intake from fast food can lead to water retention in the body, potentially causing discomforts such as stomach pain and abdominal bloating. The correlation between fast food consumption among adults and wealth is positive, while it is negative with age. This is expected to increase the demand for anti-obesity drugs, surging the market growth.

Enhancing pharmaceutical research and development

The success of a new pharmaceutical product in generating long-term profits is contingent upon the pricing strategy implemented by companies across various regions, the projected sales volume at those prices, and the probability of a successful drug development process, which significantly impacts research and development expenses. In addition, government programs and policies significantly influence the pharmaceutical industry's private spending for research and development. This impact is achieved through diverse methods, including boosting the need for prescribed medications, financing fundamental research, overseeing clinical trials, and issuing vaccine guidance that impacts both supply and demand.

Market Restraining Factors

Lack of awareness and adoption of medication

The fitness industry is rapidly evolving with a growing ecosystem comprising customers, equipment and service suppliers, complementary sectors, and public programs. There is a growing trend among individuals to prioritize fitness and monitor their daily routines and habits. The fitness industry is evolving and becoming more dynamic due to globalization and the easy accessibility of knowledge. This enhances and reinforces traditional practices and exercises. Also, gyms and other natural ways are being preferred to lose weight by the general population as there is a lack of awareness regarding anti-obesity drugs, which is expected to hinder the anti-obesity drugs market growth during the projected period.

Drug Type Outlook

Based on drug type, the anti-obesity drugs market is segmented into prescription drugs and over the counter drugs. The prescription drugs segment dominated the anti-obesity drugs market with maximum revenue share in 2022. The growth is attributed due to the presence of established players who have obtained regulatory approval for their products. These enterprises are promoting the acceptance for such commodities by enhancing their investment in research and development programs and forming strategic alliances to launch efficient remedies.

Mechanism of Action Outlook

On the basis of mechanism of action, the anti-obesity drugs market is divided into centrally acting anti-obesity drugs and peripherally acting anti-obesity drugs. The peripherally acting segment procured a substantial revenue share in the anti-obesity drugs market in 2022. This is because peripherally acting anti-obesity agents refer to pharmaceuticals that aid in weight reduction without impacting the brain or appetite suppression. This product functions as a pancreatic lipase inhibitor, effectively impeding the breakdown of fat in the gastrointestinal tract and ultimately leading to a reduction in the absorption of fat in the intestines.

Route of Administration Outlook

By route of administration, the anti-obesity drugs market is classified into oral route and subcutaneous route. The oral route segment witnessed the largest revenue share in the anti-obesity drugs market in 2022. This is because oral drug delivery is a highly preferred administration route for the anti-obesity drug due to its noninvasive nature, high patient compliance, ease of handling, and lack of requirement for specific sterile conditions. Various types of nanoparticles (NPs), hydrogels, microparticles, or combinations of them have been employed to enhance bioavailability or target specificity in the gut.

Distribution Channel Outlook

Based on the distribution channel, the anti-obesity drugs market is bifurcated into hospital pharmacies, retail pharmacies and online pharmacies. The online pharmacies segment recorded a significant revenue share in the anti-obesity drugs market in 2022. This is due to the rise in e-pharmacy usage, which has led to greater accessibility of anti-obesity medication for patients, streamlining the drug procurement process. In addition, the chronic condition of obesity requires the patient to obtain a refill in order to maintain the long-term treatment plan. This can lead to increased utilization of anti-obesity medications through online pharmacy distribution channels, driving the segment's growth during the projected period.

Regional Outlook

Region-wise, the anti-obesity drugs market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America region led the anti-obesity drugs market by generating the maximum revenue share in 2022. The growth of the anti-obesity drugs market in the region is primarily fueled by the rise in the number of individuals who are obese and the significant healthcare spending on anti-obesity drugs. Moreover, the market growth is anticipated to be driven by the heightened awareness among the populace regarding the grave chronic ailments associated with obesity and the surge in clinical trials due to increased investment by major industry players in research and development endeavors.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Pfizer, Inc., Boehringer Ingelheim International GmbH, GlaxoSmithKline PLC, Novo Nordisk A/S, Rhythm Pharmaceuticals, Inc., Gelesis Holdings Inc. (PureTech Health), Currax Pharmaceuticals LLC (Currax Holdings USA LLC), Vivus LLC, CHEPLAPHARM Arzneimittel GmbH (Braun Beteiligungs GmbH) and KVK Tech, Inc.

Scope of the Study

Market Segments covered in the Report:

By Drug Type

Prescription Drugs
Over The Counter Drugs

By Mechanism of Action

Centrally Acting
Peripherally Acting

By Route Of Administration

Oral Route
Subcutaneous Route

By Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Geography

North America
- US
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA

Companies Profiled

Pfizer, Inc.
Boehringer Ingelheim International GmbH
GlaxoSmithKline PLC
Novo Nordisk A/S
Rhythm Pharmaceuticals, Inc.
Gelesis Holdings Inc. (PureTech Health)
Currax Pharmaceuticals LLC (Currax Holdings USA LLC)
Vivus LLC
CHEPLAPHARM Arzneimittel GmbH (Braun Beteiligungs GmbH)
KVK Tech, Inc.

Unique Offerings from KBV Research

Exhaustive coverage
Highest number of market tables and figures
Subscription based model available
Guaranteed best price
Assured post sales research support with 10% customization free

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 Global Anti-Obesity Drugs Market, by Drug Type
- 1.4.2 Global Anti-Obesity Drugs Market, by Mechanism of Action
- 1.4.3 Global Anti-Obesity Drugs Market, by Route Of Administration
- 1.4.4 Global Anti-Obesity Drugs Market, by Distribution Channel
- 1.4.5 Global Anti-Obesity Drugs Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview

2.1 Introduction
- 2.1.1 Overview
  - 2.1.1.1 Market composition & scenario
2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints

Chapter 3. Global Anti-Obesity Drugs Market by Drug Type

3.1 Global Prescription Drugs Market by Region
3.2 Global Over The Counter Drugs Market by Region

Chapter 4. Global Anti-Obesity Drugs Market by Mechanism of Action

4.1 Global Centrally Acting Market by Region
4.2 Global Peripherally Acting Market by Region

Chapter 5. Global Anti-Obesity Drugs Market by Route Of Administration

5.1 Global Oral Route Market by Region
5.2 Global Subcutaneous Route Market by Region

Chapter 6. Global Anti-Obesity Drugs Market by Distribution Channel

6.1 Global Hospital Pharmacies Market by Region
6.2 Global Retail Pharmacies Market by Region
6.3 Global Online Pharmacies Market by Region

Chapter 7. Global Anti-Obesity Drugs Market by Region

7.1 North America Anti-Obesity Drugs Market
- 7.1.1 North America Anti-Obesity Drugs Market by Drug Type
  - 7.1.1.1 North America Prescription Drugs Market by Country
  - 7.1.1.2 North America Over The Counter Drugs Market by Country
- 7.1.2 North America Anti-Obesity Drugs Market by Mechanism of Action
  - 7.1.2.1 North America Centrally Acting Market by Country
  - 7.1.2.2 North America Peripherally Acting Market by Country
- 7.1.3 North America Anti-Obesity Drugs Market by Route Of Administration
  - 7.1.3.1 North America Oral Route Market by Country
  - 7.1.3.2 North America Subcutaneous Route Market by Country
- 7.1.4 North America Anti-Obesity Drugs Market by Distribution Channel
  - 7.1.4.1 North America Hospital Pharmacies Market by Country
  - 7.1.4.2 North America Retail Pharmacies Market by Country
  - 7.1.4.3 North America Online Pharmacies Market by Country
- 7.1.5 North America Anti-Obesity Drugs Market by Country
  - 7.1.5.1 US Anti-Obesity Drugs Market
    - 7.1.5.1.1 US Anti-Obesity Drugs Market by Drug Type
    - 7.1.5.1.2 US Anti-Obesity Drugs Market by Mechanism of Action
    - 7.1.5.1.3 US Anti-Obesity Drugs Market by Route Of Administration
    - 7.1.5.1.4 US Anti-Obesity Drugs Market by Distribution Channel
  - 7.1.5.2 Canada Anti-Obesity Drugs Market
    - 7.1.5.2.1 Canada Anti-Obesity Drugs Market by Drug Type
    - 7.1.5.2.2 Canada Anti-Obesity Drugs Market by Mechanism of Action
    - 7.1.5.2.3 Canada Anti-Obesity Drugs Market by Route Of Administration
    - 7.1.5.2.4 Canada Anti-Obesity Drugs Market by Distribution Channel
  - 7.1.5.3 Mexico Anti-Obesity Drugs Market
    - 7.1.5.3.1 Mexico Anti-Obesity Drugs Market by Drug Type
    - 7.1.5.3.2 Mexico Anti-Obesity Drugs Market by Mechanism of Action
    - 7.1.5.3.3 Mexico Anti-Obesity Drugs Market by Route Of Administration
    - 7.1.5.3.4 Mexico Anti-Obesity Drugs Market by Distribution Channel
  - 7.1.5.4 Rest of North America Anti-Obesity Drugs Market
    - 7.1.5.4.1 Rest of North America Anti-Obesity Drugs Market by Drug Type
    - 7.1.5.4.2 Rest of North America Anti-Obesity Drugs Market by Mechanism of Action
    - 7.1.5.4.3 Rest of North America Anti-Obesity Drugs Market by Route Of Administration
    - 7.1.5.4.4 Rest of North America Anti-Obesity Drugs Market by Distribution Channel
7.2 Europe Anti-Obesity Drugs Market
- 7.2.1 Europe Anti-Obesity Drugs Market by Drug Type
  - 7.2.1.1 Europe Prescription Drugs Market by Country
  - 7.2.1.2 Europe Over The Counter Drugs Market by Country
- 7.2.2 Europe Anti-Obesity Drugs Market by Mechanism of Action
  - 7.2.2.1 Europe Centrally Acting Market by Country
  - 7.2.2.2 Europe Peripherally Acting Market by Country
- 7.2.3 Europe Anti-Obesity Drugs Market by Route Of Administration
  - 7.2.3.1 Europe Oral Route Market by Country
  - 7.2.3.2 Europe Subcutaneous Route Market by Country
- 7.2.4 Europe Anti-Obesity Drugs Market by Distribution Channel
  - 7.2.4.1 Europe Hospital Pharmacies Market by Country
  - 7.2.4.2 Europe Retail Pharmacies Market by Country
  - 7.2.4.3 Europe Online Pharmacies Market by Country
- 7.2.5 Europe Anti-Obesity Drugs Market by Country
  - 7.2.5.1 Germany Anti-Obesity Drugs Market
    - 7.2.5.1.1 Germany Anti-Obesity Drugs Market by Drug Type
    - 7.2.5.1.2 Germany Anti-Obesity Drugs Market by Mechanism of Action
    - 7.2.5.1.3 Germany Anti-Obesity Drugs Market by Route Of Administration
    - 7.2.5.1.4 Germany Anti-Obesity Drugs Market by Distribution Channel
  - 7.2.5.2 UK Anti-Obesity Drugs Market
    - 7.2.5.2.1 UK Anti-Obesity Drugs Market by Drug Type
    - 7.2.5.2.2 UK Anti-Obesity Drugs Market by Mechanism of Action
    - 7.2.5.2.3 UK Anti-Obesity Drugs Market by Route Of Administration
    - 7.2.5.2.4 UK Anti-Obesity Drugs Market by Distribution Channel
  - 7.2.5.3 France Anti-Obesity Drugs Market
    - 7.2.5.3.1 France Anti-Obesity Drugs Market by Drug Type
    - 7.2.5.3.2 France Anti-Obesity Drugs Market by Mechanism of Action
    - 7.2.5.3.3 France Anti-Obesity Drugs Market by Route Of Administration
    - 7.2.5.3.4 France Anti-Obesity Drugs Market by Distribution Channel
  - 7.2.5.4 Russia Anti-Obesity Drugs Market
    - 7.2.5.4.1 Russia Anti-Obesity Drugs Market by Drug Type
    - 7.2.5.4.2 Russia Anti-Obesity Drugs Market by Mechanism of Action
    - 7.2.5.4.3 Russia Anti-Obesity Drugs Market by Route Of Administration
    - 7.2.5.4.4 Russia Anti-Obesity Drugs Market by Distribution Channel
  - 7.2.5.5 Spain Anti-Obesity Drugs Market
    - 7.2.5.5.1 Spain Anti-Obesity Drugs Market by Drug Type
    - 7.2.5.5.2 Spain Anti-Obesity Drugs Market by Mechanism of Action
    - 7.2.5.5.3 Spain Anti-Obesity Drugs Market by Route Of Administration
    - 7.2.5.5.4 Spain Anti-Obesity Drugs Market by Distribution Channel
  - 7.2.5.6 Italy Anti-Obesity Drugs Market
    - 7.2.5.6.1 Italy Anti-Obesity Drugs Market by Drug Type
    - 7.2.5.6.2 Italy Anti-Obesity Drugs Market by Mechanism of Action
    - 7.2.5.6.3 Italy Anti-Obesity Drugs Market by Route Of Administration
    - 7.2.5.6.4 Italy Anti-Obesity Drugs Market by Distribution Channel
  - 7.2.5.7 Rest of Europe Anti-Obesity Drugs Market
    - 7.2.5.7.1 Rest of Europe Anti-Obesity Drugs Market by Drug Type
    - 7.2.5.7.2 Rest of Europe Anti-Obesity Drugs Market by Mechanism of Action
    - 7.2.5.7.3 Rest of Europe Anti-Obesity Drugs Market by Route Of Administration
    - 7.2.5.7.4 Rest of Europe Anti-Obesity Drugs Market by Distribution Channel
7.3 Asia Pacific Anti-Obesity Drugs Market
- 7.3.1 Asia Pacific Anti-Obesity Drugs Market by Drug Type
  - 7.3.1.1 Asia Pacific Prescription Drugs Market by Country
  - 7.3.1.2 Asia Pacific Over The Counter Drugs Market by Country
- 7.3.2 Asia Pacific Anti-Obesity Drugs Market by Mechanism of Action
  - 7.3.2.1 Asia Pacific Centrally Acting Market by Country
  - 7.3.2.2 Asia Pacific Peripherally Acting Market by Country
- 7.3.3 Asia Pacific Anti-Obesity Drugs Market by Route Of Administration
  - 7.3.3.1 Asia Pacific Oral Route Market by Country
  - 7.3.3.2 Asia Pacific Subcutaneous Route Market by Country
- 7.3.4 Asia Pacific Anti-Obesity Drugs Market by Distribution Channel
  - 7.3.4.1 Asia Pacific Hospital Pharmacies Market by Country
  - 7.3.4.2 Asia Pacific Retail Pharmacies Market by Country
  - 7.3.4.3 Asia Pacific Online Pharmacies Market by Country
- 7.3.5 Asia Pacific Anti-Obesity Drugs Market by Country
  - 7.3.5.1 China Anti-Obesity Drugs Market
    - 7.3.5.1.1 China Anti-Obesity Drugs Market by Drug Type
    - 7.3.5.1.2 China Anti-Obesity Drugs Market by Mechanism of Action
    - 7.3.5.1.3 China Anti-Obesity Drugs Market by Route Of Administration
    - 7.3.5.1.4 China Anti-Obesity Drugs Market by Distribution Channel
  - 7.3.5.2 Japan Anti-Obesity Drugs Market
    - 7.3.5.2.1 Japan Anti-Obesity Drugs Market by Drug Type
    - 7.3.5.2.2 Japan Anti-Obesity Drugs Market by Mechanism of Action
    - 7.3.5.2.3 Japan Anti-Obesity Drugs Market by Route Of Administration
    - 7.3.5.2.4 Japan Anti-Obesity Drugs Market by Distribution Channel
  - 7.3.5.3 India Anti-Obesity Drugs Market
    - 7.3.5.3.1 India Anti-Obesity Drugs Market by Drug Type
    - 7.3.5.3.2 India Anti-Obesity Drugs Market by Mechanism of Action
    - 7.3.5.3.3 India Anti-Obesity Drugs Market by Route Of Administration
    - 7.3.5.3.4 India Anti-Obesity Drugs Market by Distribution Channel
  - 7.3.5.4 South Korea Anti-Obesity Drugs Market
    - 7.3.5.4.1 South Korea Anti-Obesity Drugs Market by Drug Type
    - 7.3.5.4.2 South Korea Anti-Obesity Drugs Market by Mechanism of Action
    - 7.3.5.4.3 South Korea Anti-Obesity Drugs Market by Route Of Administration
    - 7.3.5.4.4 South Korea Anti-Obesity Drugs Market by Distribution Channel
  - 7.3.5.5 Singapore Anti-Obesity Drugs Market
    - 7.3.5.5.1 Singapore Anti-Obesity Drugs Market by Drug Type
    - 7.3.5.5.2 Singapore Anti-Obesity Drugs Market by Mechanism of Action
    - 7.3.5.5.3 Singapore Anti-Obesity Drugs Market by Route Of Administration
    - 7.3.5.5.4 Singapore Anti-Obesity Drugs Market by Distribution Channel
  - 7.3.5.6 Malaysia Anti-Obesity Drugs Market
    - 7.3.5.6.1 Malaysia Anti-Obesity Drugs Market by Drug Type
    - 7.3.5.6.2 Malaysia Anti-Obesity Drugs Market by Mechanism of Action
    - 7.3.5.6.3 Malaysia Anti-Obesity Drugs Market by Route Of Administration
    - 7.3.5.6.4 Malaysia Anti-Obesity Drugs Market by Distribution Channel
  - 7.3.5.7 Rest of Asia Pacific Anti-Obesity Drugs Market
    - 7.3.5.7.1 Rest of Asia Pacific Anti-Obesity Drugs Market by Drug Type
    - 7.3.5.7.2 Rest of Asia Pacific Anti-Obesity Drugs Market by Mechanism of Action
    - 7.3.5.7.3 Rest of Asia Pacific Anti-Obesity Drugs Market by Route Of Administration
    - 7.3.5.7.4 Rest of Asia Pacific Anti-Obesity Drugs Market by Distribution Channel
7.4 LAMEA Anti-Obesity Drugs Market
- 7.4.1 LAMEA Anti-Obesity Drugs Market by Drug Type
  - 7.4.1.1 LAMEA Prescription Drugs Market by Country
  - 7.4.1.2 LAMEA Over The Counter Drugs Market by Country
- 7.4.2 LAMEA Anti-Obesity Drugs Market by Mechanism of Action
  - 7.4.2.1 LAMEA Centrally Acting Market by Country
  - 7.4.2.2 LAMEA Peripherally Acting Market by Country
- 7.4.3 LAMEA Anti-Obesity Drugs Market by Route Of Administration
  - 7.4.3.1 LAMEA Oral Route Market by Country
  - 7.4.3.2 LAMEA Subcutaneous Route Market by Country
- 7.4.4 LAMEA Anti-Obesity Drugs Market by Distribution Channel
  - 7.4.4.1 LAMEA Hospital Pharmacies Market by Country
  - 7.4.4.2 LAMEA Retail Pharmacies Market by Country
  - 7.4.4.3 LAMEA Online Pharmacies Market by Country
- 7.4.5 LAMEA Anti-Obesity Drugs Market by Country
  - 7.4.5.1 Brazil Anti-Obesity Drugs Market
    - 7.4.5.1.1 Brazil Anti-Obesity Drugs Market by Drug Type
    - 7.4.5.1.2 Brazil Anti-Obesity Drugs Market by Mechanism of Action
    - 7.4.5.1.3 Brazil Anti-Obesity Drugs Market by Route Of Administration
    - 7.4.5.1.4 Brazil Anti-Obesity Drugs Market by Distribution Channel
  - 7.4.5.2 Argentina Anti-Obesity Drugs Market
    - 7.4.5.2.1 Argentina Anti-Obesity Drugs Market by Drug Type
    - 7.4.5.2.2 Argentina Anti-Obesity Drugs Market by Mechanism of Action
    - 7.4.5.2.3 Argentina Anti-Obesity Drugs Market by Route Of Administration
    - 7.4.5.2.4 Argentina Anti-Obesity Drugs Market by Distribution Channel
  - 7.4.5.3 UAE Anti-Obesity Drugs Market
    - 7.4.5.3.1 UAE Anti-Obesity Drugs Market by Drug Type
    - 7.4.5.3.2 UAE Anti-Obesity Drugs Market by Mechanism of Action
    - 7.4.5.3.3 UAE Anti-Obesity Drugs Market by Route Of Administration
    - 7.4.5.3.4 UAE Anti-Obesity Drugs Market by Distribution Channel
  - 7.4.5.4 Saudi Arabia Anti-Obesity Drugs Market
    - 7.4.5.4.1 Saudi Arabia Anti-Obesity Drugs Market by Drug Type
    - 7.4.5.4.2 Saudi Arabia Anti-Obesity Drugs Market by Mechanism of Action
    - 7.4.5.4.3 Saudi Arabia Anti-Obesity Drugs Market by Route Of Administration
    - 7.4.5.4.4 Saudi Arabia Anti-Obesity Drugs Market by Distribution Channel
  - 7.4.5.5 South Africa Anti-Obesity Drugs Market
    - 7.4.5.5.1 South Africa Anti-Obesity Drugs Market by Drug Type
    - 7.4.5.5.2 South Africa Anti-Obesity Drugs Market by Mechanism of Action
    - 7.4.5.5.3 South Africa Anti-Obesity Drugs Market by Route Of Administration
    - 7.4.5.5.4 South Africa Anti-Obesity Drugs Market by Distribution Channel
  - 7.4.5.6 Nigeria Anti-Obesity Drugs Market
    - 7.4.5.6.1 Nigeria Anti-Obesity Drugs Market by Drug Type
    - 7.4.5.6.2 Nigeria Anti-Obesity Drugs Market by Mechanism of Action
    - 7.4.5.6.3 Nigeria Anti-Obesity Drugs Market by Route Of Administration
    - 7.4.5.6.4 Nigeria Anti-Obesity Drugs Market by Distribution Channel
  - 7.4.5.7 Rest of LAMEA Anti-Obesity Drugs Market
    - 7.4.5.7.1 Rest of LAMEA Anti-Obesity Drugs Market by Drug Type
    - 7.4.5.7.2 Rest of LAMEA Anti-Obesity Drugs Market by Mechanism of Action
    - 7.4.5.7.3 Rest of LAMEA Anti-Obesity Drugs Market by Route Of Administration
    - 7.4.5.7.4 Rest of LAMEA Anti-Obesity Drugs Market by Distribution Channel

Chapter 8. Company Profiles

8.1 Pfizer, Inc.
- 8.1.1 Company Overview
- 8.1.2 Financial Analysis
- 8.1.3 Regional & Segmental Analysis
- 8.1.4 Research & Development Expense
8.2 Boehringer Ingelheim International Gmbh
- 8.2.1 Company Overview
- 8.2.2 Financial Analysis
- 8.2.3 Regional & Segmental Analysis
- 8.2.4 Research & Development Expenses
- 8.2.5 Recent strategies and developments:
  - 8.2.5.1 Partnerships, Collaborations, and Agreements:
8.3 GlaxoSmithKline PLC (GSK)
- 8.3.1 Company Overview
- 8.3.2 Financial Analysis
- 8.3.3 Regional Analysis
- 8.3.4 Research & Development Expense
- 8.3.5 Recent strategies and developments:
  - 8.3.5.1 Acquisition and Mergers:
8.4 Novo Nordisk A/S
- 8.4.1 Company Overview
- 8.4.2 Financial Analysis
- 8.4.3 Segmental & Regional Analysis
- 8.4.4 Research & Development Expenses
- 8.4.5 Recent strategies and developments:
  - 8.4.5.1 Approvals and Trials:
8.5 Rhythm Pharmaceuticals, Inc.
- 8.5.1 Company Overview
- 8.5.2 Financial Analysis
- 8.5.3 Research & Development Expenses
8.6 Gelesis Holdings Inc (PureTech Health)
- 8.6.1 Company Overview
- 8.6.2 Financial Analysis
- 8.6.3 Research & Development Expenses
- 8.6.4 Recent strategies and developments:
  - 8.6.4.1 Partnerships, Collaborations, and Agreements:
  - 8.6.4.2 Approvals and Trials:
8.7 Currax Pharmaceuticals LLC (Currax Holdings USA LLC)
- 8.7.1 Company Overview
- 8.7.2 Recent strategies and developments:
  - 8.7.2.1 Acquisition and Mergers:
8.8 Vivus LLC
- 8.8.1 Company Overview
- 8.8.2 Recent strategies and developments:
  - 8.8.2.1 Approvals and Trials:
8.9 CHEPLAPHARM Arzneimittel GmbH (Braun Beteiligungs GmbH)
- 8.9.1 Company Overview
8.10. KVK Tech, Inc.
- 8.10.1 Company Overview

抗肥満薬の世界市場規模、シェア、産業動向分析レポート：薬剤タイプ別、作用機序別、投与経路別（経口投与、皮下投与）、流通チャネル別、地域別展望と予測、2023～2029年

Global Anti-Obesity Drugs Market Size, Share & Industry Trends Analysis Report By Drug Type, By Mechanism of Action, By Route Of Administration (Oral Route and Subcutaneous Route), By Distribution Channel, By Regional Outlook and Forecast, 2023 - 2029

目次

第1章市場範囲と調査手法

第2章市場概要

第3章世界の抗肥満薬市場：薬剤タイプ別

第4章世界の抗肥満薬市場：作用機序別

第5章世界の抗肥満薬市場：投与経路別

第6章世界の抗肥満薬市場：流通チャネル別

第7章世界の抗肥満薬市場：地域別

第8章企業プロファイル

LIST OF TABLES

Scope of the Study

Table of Contents

Chapter 1. Market Scope & Methodology

Chapter 2. Market Overview

Chapter 3. Global Anti-Obesity Drugs Market by Drug Type

Chapter 4. Global Anti-Obesity Drugs Market by Mechanism of Action

Chapter 5. Global Anti-Obesity Drugs Market by Route Of Administration

Chapter 6. Global Anti-Obesity Drugs Market by Distribution Channel

Chapter 7. Global Anti-Obesity Drugs Market by Region

Chapter 8. Company Profiles

抗肥満薬の世界市場規模、シェア、産業動向分析レポート：薬剤タイプ別、作用機序別、投与経路別（経口投与、皮下投与）、流通チャネル別、地域別展望と予測、2023～2029年

Global Anti-Obesity Drugs Market Size, Share & Industry Trends Analysis Report By Drug Type, By Mechanism of Action, By Route Of Administration (Oral Route and Subcutaneous Route), By Distribution Channel, By Regional Outlook and Forecast, 2023 - 2029

目次

第1章 市場範囲と調査手法

第2章 市場概要

第3章 世界の抗肥満薬市場：薬剤タイプ別

第4章 世界の抗肥満薬市場：作用機序別

第5章 世界の抗肥満薬市場：投与経路別

第6章 世界の抗肥満薬市場：流通チャネル別

第7章 世界の抗肥満薬市場：地域別

第8章 企業プロファイル

LIST OF TABLES

Scope of the Study

Table of Contents

Chapter 1. Market Scope & Methodology

Chapter 2. Market Overview

Chapter 3. Global Anti-Obesity Drugs Market by Drug Type

Chapter 4. Global Anti-Obesity Drugs Market by Mechanism of Action

Chapter 5. Global Anti-Obesity Drugs Market by Route Of Administration

Chapter 6. Global Anti-Obesity Drugs Market by Distribution Channel

Chapter 7. Global Anti-Obesity Drugs Market by Region

Chapter 8. Company Profiles

第1章市場範囲と調査手法

第2章市場概要

第3章世界の抗肥満薬市場：薬剤タイプ別

第4章世界の抗肥満薬市場：作用機序別

第5章世界の抗肥満薬市場：投与経路別

第6章世界の抗肥満薬市場：流通チャネル別

第7章世界の抗肥満薬市場：地域別

第8章企業プロファイル